Fundraising Fox

Ra Medical Systems

Fort Mill, US · Delaware corporation

Biotech

Founders & leadership

DA
David A. JenkinsExecutive
JW
Jonathan Will McGuireExecutive
SP
Steven PasseyExecutive

Board

SM
Susanne MelineBoard director
JC
James CarusoBoard director
MC
Martin ColombattoBoard director

Reported raises · per SEC filings

Form D private placements

$98M disclosed across 5 rounds · 2016–2023

▶$8MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David A. JenkinsDirector, Executive Officer
  • James CarusoDirector
  • Martin ColombattoDirector
  • Jonathan Will McGuireExecutive Officer, Promoter
  • Susanne MelineDirector
  • Steven PasseyExecutive Officer
Offering amount
$8M
Amount sold
$8M
Sales commissions
$640K
Placement agents
Ladenburg Thalmann & Co., Inc.
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedAug 2022 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Susanne MelineDirector
  • Brian ConnExecutive Officer
  • Joan StafslienDirector
  • Martin ColombattoDirector
  • Richard Mejia, Jr.Director
  • Will McGuireExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
Sales commissions
$497.3K
Finders' fees
$497.3K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.3MraisedJul 2018 · 64 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey KrawsExecutive Officer
  • Maurice BuchbinderDirector
  • Dean IrwinExecutive Officer, Director
  • Martin BursteinDirector
  • Melissa BursteinExecutive Officer, Director
  • Martin ColombattoDirector
  • Richard HeymannDirector
  • Andrew JacksonExecutive Officer
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Aug 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60.2MraisedJun 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean IrwinExecutive Officer, Director
  • Richard HeymannDirector
  • Martin ColombattoDirector
  • Andrew JacksonExecutive Officer
  • Maurice BuchbinderDirector
  • Jeffrey KrawsExecutive Officer
  • Martin BursteinDirector
  • Melissa BursteinExecutive Officer, Director
Offering amount
$60.2M
Amount sold
$60.2M
First sale
Jun 2018
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.3MraisedJun 2018 · 49 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew JacksonExecutive Officer
  • Maurice BuchbinderDirector
  • Martin BursteinDirector
  • Dean IrwinExecutive Officer, Director
  • Jeffrey KrawsExecutive Officer
  • Richard HeymannDirector
  • Martin ColombattoDirector
  • Melissa BursteinExecutive Officer, Director
Offering amount
$19M
Amount sold
$18.3M
First sale
Sep 2017
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Ra Medical Systems (RMED) Raises $7.6 Million Through Completed At-The-Market Facilitystreetinsider.com · Oct 2022Ra Medical Raises $66.3M in Trading Debut - San Diego Business Journalsdbj.com · Sep 2018Ra Medical amends IPO plan | MedTech Divemedtechdive.com · Sep 2018

Frequently asked questions

How much funding has Ra Medical Systems raised?
Ra Medical Systems has disclosed $98M raised across 5 rounds.
Where is Ra Medical Systems headquartered?
Ra Medical Systems is headquartered in Fort Mill, US.